Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice (Q84069787)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556046%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556046%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556046%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

S D Premaratna

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556046%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

E Manickam

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556046%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

D P Begg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556046%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

D J Rayment

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556046%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

A Hafandi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556046%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

M Jois

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556046%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

R S Weisinger

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556046%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

10 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556046%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556046%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556046%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556046%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

233-243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556046%20AND%20SRC:MED&resulttype=core&format=json

Leptin regulates ACE activity in mice.

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Comorbidities of obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Increased Inflammatory Properties of Adipose Tissue Macrophages Recruited During Diet-Induced Obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

A perinatal strategy to prevent coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Angiotensin II-induced effects on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Angiotensin II in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Candesartan attenuates Angiotensin II-induced mesangial cell apoptosis via TLR4/MyD88 pathway

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Effect of angiotensin converting enzyme inhibitor enalapril on body weight and composition in young rats.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

The effect of angiotensin-converting enzyme inhibition using captopril on energy balance and glucose homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

The ACE inhibitors enalapril and captopril modulate cytokine responses in Balb/c and C57Bl/6 normal mice and increase CD4(+)CD103(+)CD25(negative) splenic T cell numbers

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Enalapril in essential hypertension: a comparative study with propranolol. Enalapril in Hypertension Study Group (UK)

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Lipolysis and lipid mobilization in human adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Adiponectin acts in the brain to decrease body weight.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Adiponectin versus angiotensin II: Key pathological role of their misbalance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Vascular protection in diabetes: a pharmacological view of angiotensin II type 1 receptor blockers

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Angiotensin converting enzyme inhibition from birth reduces body weight and body fat in Sprague-Dawley rats.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Selective reduction in body fat mass and plasma leptin induced by angiotensin-converting enzyme inhibition in rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

The effect of ghrelin on water intake during dipsogenic conditions

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Glucose metabolism in mice lacking muscle glycogen synthase

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

AdipoQ is a novel adipose-specific gene dysregulated in obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

From mice to men: insights into the insulin resistance syndromes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

A stress signaling pathway in adipose tissue regulates hepatic insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Is obesity an inflammatory condition?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.95

7 January 2021